Jeffrey Chodakewitz, EVP GMDA, CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,088 shares at $164.12 ($659K) on 2018-02-05, disclosed to the SEC on 2018-02-07.
Seasonal sale ($659k) by EVP GMDA, CMO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.32 | 494 | $78K | 11.9% |
| 2 | $158.32 | 494 | $78K | 11.9% |
| 3 | $159.62 | 700 | $112K | 17.0% |
| 4 | $160.50 | 500 | $80K | 12.2% |
| 5 | $161.51 | 500 | $81K | 12.3% |
| 6 | $162.94 | 400 |
| $65K |
| 9.9% |
| 7 | $164.12 | 900 | $148K | 22.4% |
| 8 | $164.71 | 100 | $16K | 2.5% |
| Total | $161.08 avg | 4,088 | $659K | 100% |
| Filing → |
| VRTX | SELL | 2018-01-17 | $351K | — | Filing → |
| VRTX | SELL | 2018-01-03 | $756K | — | Filing → |
| VRTX | SELL | 2017-11-06 | $1.5M | — | Filing → |